AbbVie
ABBV
#28
Rank
$339.94 B
Marketcap
$192.45
Share price
-1.31%
Change (1 day)
13.02%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) - Cash on Hand

Cash on Hand as of March 2025 : $5.17 Billion USD

According to AbbVie's latest financial reports the company has $5.17 Billion USD in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

AbbVie - Cash on Hand chart (from 2011 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31$5.55 B-56.66%
2023-12-31$12.81 B38.87%
2022-12-31$9.22 B-6.11%
2021-12-31$9.83 B15.93%
2020-12-31$8.47 B-78.76%
2019-12-31$39.92 B395.27%
2018-12-31$8.06 B-17.65%
2017-12-31$9.78 B52.41%
2016-12-31$6.42 B-23.6%
2015-12-31$8.40 B0.39%
2014-12-31$8.37 B-15.37%
2013-12-31$9.89 B24.06%
2012-12-31$7.97 B1121.44%
2011-12-31$0.65 B5960.32%
2010-12-31$10.77 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Pfizer
PFE
$17.31 B 234.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
$11.78 B 127.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
$3.22 B-37.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
$8.81 B 70.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
$7.92 B 53.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
$2.59 B-49.80%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
$5.79 B 11.96%๐Ÿ‡ฌ๐Ÿ‡ง UK
AstraZeneca
AZN
$5.39 B 4.23%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
$0.94 B-81.77%๐Ÿ‡บ๐Ÿ‡ธ USA